GABARAPL1 and Alzheimer disease: The changing trends of TFEB, TOMM20, and GABARAPL1 in the qRT-PCR experiment and the external dataset were all consistent with the tendency in the GSE5281 dataset (Table 1), suggesting the three genes possessed potential values to be candidate biomarkers for AD mechanism research and clinical diagnosis.